ood allergy is a big clinical and public health problem in the world both for its frequency (on the rise) and for the risk of life-threatening events, with need of adrenaline prescription. In Europe, estimated lifetime prevalence of food allergy is 17.3% (point prevalence 6%) (1) . Peanut is one of the most common (from 0.5 up to 1.8% of allergic children in western countries) and dangerous foods due to IgE-mediated reactions. Unlike other common pediatric food allergies (eggs, milk), the peanut allergy does not resolve spontaneously over the years with the acquisition of immunological tolerance, but remains often for life (2, 3) . Besides, peanut allergy is due to a particularly high number of fatal and near fatal food-related reactions (4) 
Materials and methods
The children of the study group were selected among patients attending the outpatient clinic of Table 2 . Median values of serum sIgE to whole peanut and peanut components Logistic regression analysis and ROC curve were used to evaluate the laboratory findings. Table 1 . Characteristics of the studied population Relative to SPTs, no significant difference in wheal size was observed between allergic and tolerant patients ( Table 1 There is a great number of further studies that demonstrate the prevailing value of Ara h 2 sIgE in the diagnostic workup of peanut allergy in children, using OFC to confirm peanut clinical reactivity (3, (19) (20) (21) (22) (23) or only the medical history to evaluate the peanut allergy clinical severity (24, 25) .
Other studies show a correlation between sIgE to Ara h 2 and clinical severity of peanut allergy, demonstrating a prevalence of Ara h 2 sIgE in patients with more severe reactions (26) . 
